AD
Anna Maria Di Giacomo
Research areas: Medicine · Oncology · Cancer Immunotherapy and Biomarkers · Cutaneous Melanoma Detection and Management · Melanoma and MAPK Pathways
0000-0001-9315-2158
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- Broadening the tumor antigens panorama for cancer vaccines – All the way to the dark matter of the genome Save
- The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial Save
- Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy Save
- A Real-World Experience of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Save
- Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy Save
- Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors – A Systematic Review and Meta-Analysis Save
- A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203) Save
- From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma Save
- Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID Save
- Immunotherapy for brain metastases and primary brain tumors Save
- SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines Save